XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 39,087 $ 26,901 $ 107,906 $ 86,658
General and administrative 17,268 8,240 44,143 23,066
Total operating expenses 56,355 35,141 152,049 109,724
Loss from operations (56,355) (35,141) (152,049) (109,724)
Other income (expense), net:        
Interest expense (70) (1,748) (145) (3,094)
Interest income 5,345 1,781 15,613 2,884
Other expense (66) (295) (306) (210)
Total other income (expense), net 5,209 262 15,162 (420)
Net loss (51,146) (35,403) (136,887) (110,144)
Other comprehensive loss:        
Unrealized (loss) gain on marketable securities 119 (270) 351 (1,650)
Comprehensive loss (51,027) (35,673) (136,536) (111,794)
Net loss attributable to common stockholders $ (51,146) $ (35,403) $ (136,887) $ (110,144)
Net loss per share attributable to common stockholders—basic $ (0.73) $ (0.58) $ (1.97) $ (1.84)
Net loss per share attributable to common stockholders—diluted $ (0.73) $ (0.58) $ (1.97) $ (1.84)
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders —basic 69,855,766 60,670,294 69,645,888 59,941,384
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders—diluted 69,855,766 60,670,294 69,645,888 59,941,384